Roswell & UB Collaborate to Offer Clinical COVID-19 Drug Trial

This is very exciting news to pass along to you.  Roswell Park Comprehensive Cancer Center and the University of Buffalo have collaborated to develop and offer a drug that will specifically benefit persons who are critically ill with COVID-19.  This breakthrough could ease the need for ventilators as this drug is hopeful in that it will help save the lives of patients who are suffering to the point that they cannot breathe due to complications related to COVID-19.

This great news is according to a Press Release and the interview to follow (below).

These are the Highlights of the Clinical Drug Trial according to Roswell Park Comprehensive Cancer Center's website:

• Clinical trial will assess effectiveness of the antibody sarilumab (Kevzara)

• Part of large international COVID-19 trial sponsored by Regeneron and Sanofi

• Researchers pursuing additional clinical trials with other COVID-19 therapies

Please note and understand that this clinical trial is reserved for COVID-19 patients who are in jeopardy of dying from COVID-19

Listen to the Full Interview with Dr. Igor Puzanov, Director of the Early Phase Clinical Trials Program, Roswell Park Comprehensive Cancer Center:

7 Phrases You Hope You’ll Never Hear Again After the Pandemic

25 Natural Ways to Boost Your Immune System